Filer Snapshot

Evommune, Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0002044725.

Entity Type

Company

Total Filings

92

Latest Filing

07 May 2026

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open insider trading context
Source: SEC Forms 3/4/5

424B3 filed on 07 May 2026 for CIK 0002044725.

View Source Filing
Symbol
EVMN on NYSE
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
1891 Page Mill Rd, Palo Alto, CA
State of incorporation
DE
Fiscal year end
31 December

Quick Takeaways

  • Evommune, Inc. is an SEC filer tracked under CIK 0002044725.
  • 92 filings are listed on this profile.
  • Common form coverage includes 424B3, 10-Q, 8-K and more.

What Changed

  • Latest filing: 424B3 filed on 07 May 2026.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC Forms 3/4/5

424B3 filed on 07 May 2026 for CIK 0002044725.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 424B3 can change the filing history, ownership context, or next research path for Evommune, Inc..

Latest source-backed update
424B3 filed 07 May 2026
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: 424B3 filed 07 May 2026.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Evommune, Inc.

New fact period available

Latest financial period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

07 May 2026

Page type

Company facts

Latest period

Q1 2026

SEC-backed company facts were refreshed from filings filed on 07 May 2026.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

Evommune, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 07 May 2026.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Company intelligence

Research Evommune, Inc. from filings to ownership signals

Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.

Create free account to watch this company Open ownership signals

Active modules

3/5

Available company intelligence paths on this page.

Filings

92

SEC submissions provide the evidence trail.

Ownership context

1/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Save the company so the next source-backed change has a clear place to bring you back.

Best-of company intelligence workflow

What changed?

Start with the latest filing and active ownership modules before opening older table rows.

Why might it matter?

Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.

Where is evidence?

Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.

What to watch next?

Save the company so watchlists can bring you back when the next filing-backed update lands.

SEC-verifiable company research path

Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.

Open latest insider signals Open large-stake radar

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Available

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Open insider activity

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch Evommune, Inc. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

Evommune, Inc. has filed 92 SEC EDGAR filings since 07 Jan 2025. Common forms include 424B3, 10-Q, 8-K, EFFECT and more.

Pharmaceutical Preparations Insider transactions Latest 13F filings

Latest Filings

Recent SEC filings for Evommune, Inc. with direct links to document and filing folders.

424B3 File 333-295140

424B3

Filing date
07 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-295140

EFFECT filing

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-295140

424B3

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-42938

ARS

Filing date
21 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-42938

DEF 14A

Filing date
21 Apr 2026
Reporting date
21 Apr 2026
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2026
Reporting date
16 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-95351

SCHEDULE 13D/A filing

Filing date
19 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-95351

SCHEDULE 13D/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Feb 2026
Reporting date
17 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95351

SCHEDULE 13G filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
22 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-95351

SCHEDULE 13D filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95351

SCHEDULE 13G filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-95351

SCHEDULE 13D filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-290793

424B4

Filing date
06 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-290793

FWP

Filing date
06 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-42938

NYSE CERTIFICATION

Filing date
05 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-42938

8-A12B

Filing date
04 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-290793

FWP

Filing date
30 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-08010

DRS/A filing

Filing date
23 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-08010

DRS/A filing

Filing date
02 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-08010

DRS/A filing

Filing date
18 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-08010

DRS filing

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-534546

D filing

Filing date
08 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-534516

D filing

Filing date
08 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-534510

D filing

Filing date
08 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-534380

D filing

Filing date
07 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

Evommune, Inc. files with the SEC under CIK 0002044725. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .